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Abstract
Background: A simplified formula to calculate the predicted fractional flow reserve (FFR) in sequen-
tial coronary stenosis without balloon inflation is hereby proposed.
Methods: In patients with an indication for FFR and sequential coronary stenosis, FFR was recorded 
distally and between the lesions. The predicted FFR for each stenosis was calculated with a novel formu-
la. While treating one of the lesions, wedge pressure was measured during balloon inflation to calculate 
Pijls’ formula. FFR of the remaining lesion was finally recorded (measured FFR).
Results: Forty patients were enrolled in the study, 4 (10.0%) had a distal FFR > 0.80 and were 
excluded from the main analysis. In the remaining 36 patients, the novel formula and Pijls’ formula 
showed virtually absolute agreement (ICCa 0.999, R2 = 0.997 for the proximal lesion, R2 = 0.999 for 
the distal lesion, kappa 1.000, Se 100%, Sp 100%). The agreement between predicted and measured 
FFR was good (ICCa 0.820; 0.640–0.909, R2 = 0.717, intercept = 0.05, slope = 0.92, kappa 0.748, Se 
75%, Sp 96%). In 19 (47.5%) cases the use of the formula enabled the operator to freely decide which 
lesion should be treated first, an option not available if the percutaneous coronary intervention (PCI) 
were guided by the largest pressure drop across each lesion.
Conclusions: The predicted FFR for each lesion in sequential coronary stenosis can be accurately 
calculated by a simplified formula circumventing the need for balloon inflation. This approach provides 
the operator upfront, with detailed information on physiology, thus having a potentially high impact on 
the corresponding PCI strategy. (Cardiol J 2019; 26, 4: 310–321)
Key words: fractional flow reserve, myocardial, coronary stenosis, coronary circulation, 
percutaneous coronary intervention
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Introduction
Fractional flow reverse (FFR) is the most ex-
tensively validated test of intracoronary physiology 
to assess the hemodynamic relevance of coronary 
stenosis in patients with stable coronary artery 
disease (CAD) [1]. The utility and safety of FFR-
-guided percutaneous coronary intervention (PCI) 
have been proved in several large randomized trials 
and different clinical scenarios [2–4]. The cut-off-
value of ≤ 0.80 is currently recommended to guide 
PCI of coronary lesions [5]. 
Sequential coronary stenosis is a common 
finding [6] and the objective assessment of their 
individual severity is challenging for both the 
coronary angiogram and FFR, because the fluid 
dynamic interaction between stenosis alters their 
relative severity and obscures the determination 
of FFR for each stenosis separately [7]. De Bruyne 
and Pijls [7, 8] developed a formula for sequential 
coronary stenosis which is able to predict the FFR 
corresponding to each lesion. Nonetheless this 
method requires the measurement of coronary 
wedge pressure (Pw), which is available only after 
balloon inflation during PCI [7, 8]. This limitation 
together with the relative complexity of the calcula-
tion has prevented wide adoption of Pijls’ formula 
[9]. Simpler alternatives have been proposed, like 
guiding the decision of treatment according to the 
delta of pressured drop measured in a pullback 
along each lesion (∆P) [10], however this simpli-
fication reduces accurate quantitative physiologic 
assessment to a mere qualitative comparison (most 
severe lesion of the tandem), thus neglecting 
a considerable amount of information recorded 
during the study.
Gutiérrez-Chico et al. have recently proposed 
a simplified formula to calculate FFR in sequential 
lesions circumventing the measurement of Pw [11], 
based on the mathematical relations between the 
corrected FFR as function of Pw in Pijls’ formula: 
this is a J-shaped function, with minimal curvature, 
in which the straight part of the J corresponds to 
the physiologic range of Pw, i.e. below 30 mmHg 
(Fig. 1). Therefore, the change in FFR calculation 
for both the proximal and distal stenosis is negli-
gible within the whole Pw range that can be found 
in clinical practice. Gutiérrez-Chico et al. proposed 
using Pijls’ formula with a standard central Pw 
value of 12 mmHg [11], thus obviating the need 
for balloon inflation to measure Pw (Fig. 2). The 
APIS-S pilot study (Assessment of Physiology In 
Sequential Stenosis) aims at validating the novel 
formula vs. the standard Pijls’ formula.
Methods
Study design
This is a prospective, observational, multicen-
tre study aimed at appraising agreement between 
the novel simplified formula and Pijls’ formula, 
taken the latter as reference and at the physi-
ologic validation of the novel formula, comparing 
the predicted FFR of the untreated lesion vs. the 
measured FFR after PCI of one lesion.
Study population
Patients from six different centres in Germany, 
Poland and Spain, meeting the following inclusion 
criteria were enrolled in the study: 1) two sequen-
tial lesions with ≥ 50% diameter stenosis by visual 
estimation in the same or in adjacent vessels, with 
a reference vessel diameter (RVD) ≥ 2.25 mm 
and separated by an apparently normal segment 
≥ 10 mm, 2) a clinical indication for FFR, and 
3) a distal FFR measurement ≤ 0.80 beyond both 
lesions. Main exclusion criteria were: 1) proximal 
lesion in the left main, with an overall SYNTAX 
score ≥  33; 2) contraindication for intravenous 
adenosine; 3) contraindication for dual antiplatelet 
therapy; 4) indication for conservative/surgical 
treatment; 5) hemodynamic or electrical instability.
The study was conducted according to the 
Declaration of Helsinki and to the principles and 
standards of good clinical practice. The protocol 
was approved by the local Ethics Committee in 
each center and all patients signed specific in-
formed consent for their participation. 
Study protocol
Coronary angiography was obtained through 
femoral, radial or cubital approaches, preferably 
with a ≥ 6 French catheter. After administration of 
heparin (70–100 UI/kg), the guiding catheter was 
engaged into the ostium of the target vessel. The 
pressure line monitored through the guiding cath-
eter was zeroed and intracoronary nitroglycerin 
was administered. The pressure wire was zeroed 
within the wire sheath and then advanced until 
the pressure transducer (located in the transition 
between the radiopaque and radiolucent segments 
of the wire) reached the tip of the guiding cath-
eter. The introducer needle of the guidewire was 
then removed, saline was flushed into the guiding 
catheter and both pressure recordings were equal-
ized. Then the pressure transducer was advanced 
distally to both lesions and basal Pd/Pa distal was 
recorded. A continuous intravenous infusion of 
140 μg/kg/min adenosine was started and maintained 
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Figure 1. J-shape of Pijls’ formula to calculate fractional flow reserve (FFR) in sequential lesions as a function of 
coronary wedge pressure (Pw). Corrected FFR for the proximal (left) and distal (right) lesions as a function of Pw. The 
function has been represented in four different combinations of Pa/Pd measured distally and between the lesions: 
1) Pa/Pd combination in which only the proximal lesion is severe (blue), 2) in which only the distal lesion is severe (red); 
3) both lesions are severe (beige) and 4) no lesion is severe (green). The change in FFR estimation is minimal within 
the whole physiologic range of Pw (< 30 mmHg).
until maximal stable hyperaemia was reached. 
Then distal FFR was recorded distally to both le-
sions (d), registering the corresponding Pa(d) and 
Pd(d) values. Then the pressure transducer was 
pulled back to the segment between both lesions 
(m), and a second FFR measurement was recorded, 
registering the corresponding Pa(m) and Pd(m) 
values. Finally, the transducer was pulled back to 
the tip of the guiding catheter to check whether 
the pressures remain equalised proximal to the 
stenosis. A pressure drift of ± 3 mmHg was con-
sidered acceptable and adenosine could hence be 
stopped; otherwise the measurements should be 
repeated from the beginning.
Pd and Pa obtained distally (d) and between the 
lesions (m) were entered in the online calculator 
implemented for the study (https://journals.via-
medica.pl/cardiology_journal/pages/view/calc) to 
calculate the predicted FFR corresponding to each 
lesion according to the novel formula (Figs. 2, 3). 
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Figure 2. Simplified formula to calculate the predicted fractional flow reserve (FFR) for each lesion in sequential 
coronary stenosis. FFR (A)pred — predicted fractional flow reserve for the proximal lesion (A); FFR (B)pred — predicted 
fractional flow reserve for the distal lesion (B); Pa — pressure in the aorta; Pd — pressure distal to both lesions; Pm — 
pressure between lesions.
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Figure 3. Interface of the online calculator implemented for the study: example of calculation; A. Sequential lesions 
in the mid left anterior descending (LAD) (red arrowhead A) and in the distal LAD (red arrowhead B). Under maximal 
vasodilation with adenosine, the pressure wire measured Pa = 114 mmHg and Pd = 84 mmHg, distally to both le-
sions (white arrow), corresponding to a measured fractional flow reserve (FFR) = 0.74. After pulling the transducer 
back to a position between the lesions A and B (yellow arrow), the measurements were Pa = 111 mmHg and Pd = 
95 mmHg, corresponding to a measured FFR = 0.86 between the lesions. At this point Gutiérrez-Chico’s novel formula 
estimated the predicted FFR for each lesion, without need of the coronary wedge pressure (Pw). Since the lesion in 
the mid LAD had the most significant FFR (0.83), this lesion was stented (B). During balloon inflation, Pw was obtained 
(Pw = 15 mmHg) and the predicted FFR values for each lesion after Pijls’ formula are automatically displayed by the 
calculator. Notice the perfect agreement between both formulas. After optimal stent deployment in the mid LAD (C), 
FFR was measured distally to lesion B (white arrow), resulting in an FFR = 0.85, this is very similar to the values pre-
dicted by both Pijls’ and Chico’s formulas (0.86); Pa — pressure in the aorta; Pd — distal pressure measured at the 
transducer of the wire distally [https://journals.viamedica.pl/cardiology_journal/pages/view/calc].
Pa and Pd values in the formula corresponded to 
the values registered distally to both lesions: Pa(d) 
and Pd(d), respectively. In order to adjust for small 
fluctuations in aortic pressure, the calculator esti-
mated Pm = Pd(m) × Pa(d) / Pa(m).
Therapeutic decision tree and PCI protocol
If FFR measured distally to both lesions 
> 0.80, then no stenosis was treated and the patient 
was excluded from the head-to-head comparison 
(Fig. 4). Conversely, if the FFR measured distally 
to both lesions ≤ 0.80, at least one lesion had to 
be treated depending on the FFR predicted by the 
novel formula for each lesion, namely: 
1. If both lesions had a predicted FFR > 0.80, 
but the combination of both was distally 
≤ 0.80, one lesion had to be treated. The deci-
sion about which lesion to treat was left at the 
operator’s discretion. As a general rule, it was 
recommended to treat the lesion with the low-
est predicted FFR, but operational factors, the 
technical feasibility or the anatomic complexity 
could also be considered by the operator to 
change the decision about which lesion to treat; 
2. If only one lesion had a predicted FFR ≤ 0.80, 
then only that lesion had to be treated; 
3. If both lesions had a predicted FFR ≤ 0.80, then 
both lesions had to be treated. The operator 
could decide which lesion to treat first based 
on operational factors (Fig. 4).
During the treatment of the first lesion, Pw 
was measured as the distal pressure registered by 
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Figure 4. Flow chart for data acquisition in the APIS-S study: fractional flow reserve (FFR)-based decision tree; pFFR 
— predicted FFR; Pw — coronary wedge pressure.
the pressure wire whilst the balloon was inflated. 
PCI optimization was left at the operator’s discre-
tion and was based on angiographic standards. Once 
an optimal angiographic result had been achieved, 
a final FFR measurement was recorded, as previ-
ously described, placing the transducer at the same 
position as with the initial recording.
Statistical analysis
Continuous variables following a Gaussian 
distribution were reported as mean ± standard 
deviation, whilst they were reported as median 
(Q1–Q3) whenever a normal distribution could not 
be assumed. Nominal variables were reported as 
count (percent). The FFR predicted by the novel 
formula and by Pijls’ formula for each lesion were 
contrasted, considering the latter as a gold stand-
ard, by means of linear regression, Bland-Altman 
analysis and intraclass correlation coefficient for 
the absolute agreement (ICCa). The predicted 
FFR values were categorised as severe (≤ 0.80) or 
non-severe (> 0.80) and the agreement between 
the novel formula and Pijls’ formula was assessed 
as kappa coefficient, calculating the sensitivity 
(Se) and specificity (Sp) of the former by the cor-
responding cross-tabulation. The same methodol-
ogy was used to assess the agreement between the 
predicted FFR by both formulas and the measured 
FFR after treatment of the first lesion.
In order to estimate the impact of using the 
formula on PCI strategy, as compared with the 
common practice of using the largest pressure drop 
across each lesion (DP), the following categories 
were defined for each method: 1) no PCI (if FFR 
measured distally > 0.80), 2) PCI of 1 lesion, 3) 
PCI of both lesions. The agreement between both 
methods was assessed by means of weighted 
kappa, taking into account that the DP cannot 
predict a priori the need of intervening for both 
lesions. Likewise, the agreement between both ap-
proaches in choosing which lesion to treat first was 
tested with weighted kappa, after categorising the 
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Patient level N = 40
Male 31 (77.5%)
Age [years] 67.1 ± 9.8
BMI 28.7 ± 4.4
CV risk factors:
Hypertension 34 (85.0%)
Hypercholesterolemia 23 (57.5%)
Diabetes mellitus:
Type 2 on OAD 9 (22.5%)
Type 2 insulin-requiring 3 (7.5%)
Smoking:
Previous smoker 10 (25.0%)
Current smoker 6 (15.0%)
Family history of CHD 4 (10.0%)
Previous MI 16 (40.0%)
Previous revascularization:
PCI
CABG
21 (52.5%)
1 (2.5%)
GFR (Cockroft-Gault) [mL/min] 78.4 ± 30.9
Serum hemoglobin [g/dL] 13.0 ± 1.4
LVEF [%] 63 ± 6
Procedural variables
SYNTAX score 13.6 ± 7.2
Contrast volume [mL] 179 ± 79
Fluoroscopy time [min] 18.1 ± 9.7
Proximal lesion
Prox RCA
Mid RCA
Distal RCA
Left main
Prox LAD
Mid LAD
Prox LCx
5 (12.5%)
3 (7.5%)
1 (2.5%)
3 (7.5%)
16 (40.0%)
7 (17.5%)
5 (12.5%)
Calcification:
None to little 36 (90.0%)
Moderate to severe 4 (10.0%)
Diameter stenosis [%] 62.4 ± 12.7
Distal lesion
Mid RCA
Distal RCA
Right PDA
Right PAV
Prox LAD
Mid LAD
Dist LAD
Dist LCx
Obtuse marginal
4 (10.0%)
3 (7.5%)
1 (2.5%)
1 (2.5%)
1 (2.5%)
14 (35.0%)
11 (27.5%)
2 (5.0%)
3 (7.5%)
Calcification:
None to little
Moderate to severe
37 (92.5%)
3 (7.5%)
Diameter stenosis [%] 64.4 ± 13.3
FFR
FFR measured between lesions 0.85 ± 0.05
FFR measured distally 0.73 ± 0.07
Pw [mmHg]:
Average 14 ± 6
Range 1–26
First lesion treated:
Proximal 22 (55.0%)
Distal 14 (35%)
No lesion treated 4 (10.0%)
Both lesions treated 6 (15.0%)
FFR after treatment of first lesion 0.86 ± 0.07
Data presented as counts (percent) or as mean ± standard devia-
tion. BMI — body mass index; CABG — coronary artery bypass 
graft; CHD — coronary heart disease; CV — cardiovascular; FFR —  
fractional flow reserve; GFR — glomerular filtration rate; LAD — left 
anterior descending; LCx — left circumflex; LVEF — left ventricular 
ejection fraction; MI — myocardial infarction; OAD — oral antidi-
abetics; PAV — posteroatrioventricular; PDA — posterior descen-
ding artery; PCI — percutaneous coronary intervention; Pw —  
coronary wedge pressure; RCA — right coronary artery
Table 1. Descriptive statistics of patients, intervention and lesions.
decision in: 1) proximal first, 2) operator’s choice 
(FFR ≤ 0.80 measured distally to both lesions and 
predicted FFR by the formula were either > 0.80 
for both lesions or ≤ 0.80 for both lesions), 3) distal 
first. All statistical analyses were performed using 
the IBM SPSS 20.0 (IBM Corp, Armonk, NY, USA) 
software package.
Results
Between July 2016 and January 2018 forty 
patients with sequential coronary lesions were 
included in the study in six participating centres. 
Table 1 summarises the clinical characteristics of 
the patients and anatomical description of the le-
sions. The average SYNTAX score was relatively 
low (13.6) and left anterior descending was the 
most frequent location for the studied lesions 
(57.5% of the proximal lesions, 65.0% of the 
distal lesions), although all main vessels were 
represented. In 4 (10.0%) patients FFR measured 
distally to both lesions was > 0.80, so they were 
excluded from the main analysis of the study, but 
Æ
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their data were registered for analysis of impact 
on the strategy. In 30 (75.0%) patients only one 
lesion was hemodynamically significant, whilst in 
the remaining 6 (15.0%) cases both lesions were 
found to be significant according to the predicted 
FFR. The average Pw was 14 mmHg, ranging from 
a minimum of 1 mmHg to a maximum of 26 mmHg.
Agreement between the novel formula and 
Pijls’ formula was excellent: ICCa 0.999 for the pre-
dicted FFR of both the proximal and distal lesions 
(Fig. 5, Table 2). The predicted FFR calculated 
by the novel formula had a perfect linear relation 
with predicted FFR calculated by Pijls’ formula 
(r = 0.999, Fig. 5) and the latter could accurately be 
predicted by the former in a model of linear regres-
sion (R2 = 0.997 for the proximal lesion, R2 = 0.999 
for the distal lesion). The agreement between both 
formulas for the categorization as hemodynamically 
relevant (predicted FFR ≤ 0.80) vs. non-relevant 
(predicted FFR > 0.80) was perfect for both the 
proximal and the distal lesions (kappa 1.000, Se 
100%, Sp 100%).
The agreement between FFR predicted by the 
novel formula and the FFR measured after PCI 
of the first lesion was good: ICCa 0.820 (0.640–
–0.909), R2 = 0.717, intercept 0.05 (statistically 
non-significant), slope 0.92. For the categorization 
as hemodynamically relevant vs. non-relevant the 
agreement between predicted and measured FFR 
was also good (kappa 0.748). The formula resulted 
in one false positive (2.5%) and two false negatives 
(5.0%), corresponding to a Se of 75%, Sp of 96%, 
positive predictive value 86%, negative predictive 
value 93%. This level of agreement was almost 
identical to the one showed by the FFR predicted 
by Pijls’ formula (Fig. 6, Table 3).
Figure 5. Agreement between Gutiérrez-Chico’s novel formula and Pijls’ formula; Upper panels: Agreement for the 
proximal lesion; Lower panels: Agreement for the distal lesion. Linear regression (left) with Pijls’ formula as reference; 
Bland-Altman analysis (right); FFR — fractional flow reserve.
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Figure 6. Agreement between predicted fractional flow reserve (FFR) and measured FFR after treatment of one of the 
lesions; Upper panels: FFR predicted by Pijls’ formula; Lower panels: FFR predicted by Gutiérrez-Chico’s simplified 
formula. Linear regression (left) with the measured FFR after treatment of one lesion as reference; Bland-Altman 
analysis (right); PCI — percutaneous coronary intervention.
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Table 2. Agreement between Pijls’ formula and Gutiérrez-Chico’s simplified formula.
Pijls’  
formula
Chico’s  
formula
r R2 P ICCa
Predicted FFR for 
proximal lesion
0.82 ± 0.06 0.82 ± 0.06 0.999 0.997 < 0.0001 0.999  
(0.997–0.999)
Predicted FFR for 
distal lesion
0.85 ± 0.08 0.85 ± 0.08 0.999 0.999 < 0.0001 0.999 
(0.998–1.000)
Pijls’  
formula
Chico’s  
formula
Kappa P Se (%) Sp (%)
Proximal lesion:
Severe 15 15 1.000 < 0.0001 100 100
Non-severe 21 21
Distal lesion:
Severe 14 14 1.000 < 0.0001 100 100
Non-severe 22 22
Data presented as counts, percent, median ± standard deviation or as coefficient (95% confidence interval). ICCa — intraclass correlation  
coefficient for the absolute agreement; FFR — fractional flow reserve; Se — sensitivity; Sp — specificity
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Table 3. Agreement between predicted fractional 
flow reserve (FFR) and FFR after treatment. 
Pijls’  
formula
Chico’s  
formula
Predicted FFR 0.87 ± 0.06) 0.87 ± 0.06
Measured FFR  
after treatment  
of 1st lesion
0.86 ± 0.07
r 0.847 0.847
R2 0.717 0.717
P < 0.0001 < 0.0001
Intercept 0.06* 0.05*
Slope 0.91 0.92
ICCa 0.825  
(0.658–0.910)
0.820  
(0.640–0.909)
Kappa 0.748 0.748
False positives 1 (2.5%) 1 (2.5%)
False negatives 2 (5.0%) 2 (5.0%)
Se (%) 75 75
Sp (%) 96 96
PV (+) 86 86
PV (–) 93 93
*Statistically non-significant. Data presented as mean ± standard 
deviation, coefficient (95% confidence interval) or as count (per-
cent). ICCa — intraclass correlation coefficient for the absolute 
agreement; Se — sensitivity; Sp — specificity; PV (+) — positive 
predictive value; PV (–) — negative predictive value
Calculating predicted FFR for each lesion 
resulted in an indication for single-lesion PCI in 
30 (75.0%) cases, double-lesion PCI in 6 (15.0%) 
cases and no indication for PCI in 4 (10.0%) cases 
(Table 4). Since the approach of guiding the PCI by 
the largest DP does not enable to do an upfront in-
dication for double-lesion PCI, the weighted kappa 
for the initial PCI strategy was 0.55 (0.25–0.84). 
Regarding which lesion that should be stented 
first, calculating the predicted FFR pointed to the 
proximal lesion in 9 (25.0%) cases, the distal le-
sion in 8 (22.2%) cases, whilst it was left up to the 
operator in 19 (52.8%) of the cases: in 6 (16.7%) 
of them because both lesions were significant and 
in 13 (36.1%) of them because both lesions had 
a predicted FFR > 0.80 separately, although the 
combination had a significant result (Table 4). Since 
guiding the intervention by DP does not permit 
the facultative decision on which lesion stenting 
is first, these results corresponded to a weighted 
kappa of 0.47 (0.30–0.64).
Discussion
The key messages of this study can be sum-
marised as follows: 1) predicted FFR for each lesion 
in sequential coronary stenosis can be accurately 
calculated by a novel simplified formula, obviating 
the measurement of coronary wedge pressure, thus 
circumventing the need for balloon inflation; 2) the 
novel simplified formula is close to the absolute 
agreement with Pijls’ formula, previously validated, 
but requiring balloon inflation; 3) the FFR predicted 
by the novel simplified formula has good agreement 
with the FFR measured after treatment of one of 
the lesions, identical to the level of agreement of 
the FFR predicted by Pijls’ formula; 4) the approach 
of calculating predicted FFR for each individual le-
sion may have a substantial impact on PCI strategy 
in treating patients.
In the year 2000 Bernard de Bruyne and Nico 
Pijls proposed a formula to calculate the predicted 
FFR for each lesion in sequential coronary steno-
sis [7, 8]. By means of a sophisticated but elegant 
rationale, they demonstrated that the change in 
flow occurring if any of the lesions were removed 
could be estimated with just the pressure record-
ings obtained under maximal hyperemia before the 
Table 4. Agreement between gradient of pressure drop (DP) and the formula to plan percutaneous 
coronary intervention (PCI) strategy in sequential lesions: weighted kappa.
PCI strategy (n = 12) Formula
Weighted kappaNo PCI 1 lesion PCI Both lesions PCI
DP No PCI 4 0 0
0.55  
(0.25–0.84)1 lesion PCI 0 30 6
Both lesions PCI 0 0 0
Proximal first Operator’s 
choice
Distal first Weighted kappa
DP Proximal first 9 15 0
0.47  
(0.30–0.64)Operator’s choice 0 0 0
Distal first 0 4 8
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intervention. This formula was validated in both 
an experimental animal model [7] and in a clinical 
setting [8]. Nonetheless, their formula entailed 
a practical drawback that ultimately prevented its 
widespread generalization for clinical use: it re-
quired the calculation of coronary wedge pressure 
(Pw) and this could be only measured while inflating 
a balloon in one of the lesions. That meant that PCI 
should start before predicted FFR values were avail-
able. That was the main reason why FFR-guided 
PCI in sequential stenosis has rather followed 
the so called “delta approach”: the lesion through 
which the largest pressure drop occurs (DP) was 
considered the most functionally severe and it was 
hence treated first. The delta approach is easier to 
implement in the cath-lab routine, but it has some 
intrinsic limitations, because it neglects the accurate 
depiction of coronary physiology that de Bruyne and 
Pijls unravelled. The delta approach can only decide 
which lesion is most severe, in dichotomous terms, 
but it cannot unveil upfront whether both lesions 
are functionally relevant or whether no lesion is 
functionally relevant itself but the combination of 
both is. These situations are not seldom (54.3% in 
the present series) and their identification might be 
useful for operators to plan PCI accordingly.
A chance to incorporate the accuracy of Pijls’ 
formula into clinical practice came from a pragmatic 
observation that predicted FFR, expressed as 
a function of Pw, followed a J-shaped curve, with the 
straight part of the J corresponding to the physi-
ologic and pathologic range of Pw (< 30 mmHg). 
Rephrased in clinical terms, the predicted FFR 
values remained stable and practically unchanged 
along the whole clinical range of Pw. Ironically the 
parameter precluding adoption of Pijls’ formula 
for so many years (Pw) ended up not playing such 
an instrumental role. Based on this observation, 
Gutiérrez-Chico et al. proposed to using a central 
Pw value for cases in which estimation of refined 
physiology might be deemed important [11]. The 
current study is a clinical validation of this ap-
proach, taking a central value of Pw = 12 mmHg 
(Fig. 2). The series confirms the initial premise for 
the application of the simplified formula: in an un-
selected sample of 35 patients Pw was < 30 mmHg 
in all cases (minimal and maximal values 1 and 
26 mmHg, respectively). Under these conditions, 
Gutiérrez-Chico’s simplified approach obviating 
the need for balloon inflation resulted in practically 
identical values of predicted FFR to the ones ob-
tained by the classical Pijls’ formula. As predicted 
by the mathematical model, both approaches were 
close to absolute agreement whenever compared 
as continuous (predicted FFR) or as dichotomous 
variables (relevant vs. non-relevant).
Agreement between predicted  
and measured FFR
The agreement between the FFR predicted 
by the novel formula and the real FFR measured 
after treatment of one of the lesions was also good 
and similar to the agreement reported by Pijls in 
his original article [8]: as a continuous variable, 
ICCa was 0.820, whilst as a dichotomous variable 
(relevant vs. non-relevant) the kappa coefficient 
was 0.748, both considered as indicative of good 
agreement. As observed in the Bland-Altman and 
in the lineal regression analysis, the predicted 
FFR did not incur any proportional bias (slope 
= 0.92), although it tended to be a subtle but non-
significant constant bias (intercept = 0.05), inclined 
to slightly underestimate severity of the lesion. 
This observation had been already described 
by de Bruyne and Pijls in their original articles 
[7, 8] and might be most likely explained by a slight 
underestimation of the increase in coronary flow 
through the remaining stenosis after treatment of 
the first one, or because a residual pressure drop 
is often detected after PCI [12, 13]. Interestingly, 
whilst in the original animal model the predicted 
FFR never overestimated the true severity [7], the 
clinical validation reported however, some cases of 
overestimation [8]. The present results are in line 
with the original clinical study, finding a subtle non-
significant trend to constant underestimation of se-
verity, but with some cases of slight overestimation 
that might correspond to cases with side branches 
taking-off between lesions. This could explain the 
higher specificity than sensitivity of the method. 
In light of the overall good diagnostic accuracy and 
of the existence of some cases of overestimation, 
further attempts to refine the calculation by adding 
some constant correction factor are not justified.
Impact of the formula on planning  
the PCI strategy
This novel simplified approach to calculate FFR 
in sequential lesions provides the interventional 
cardiologist with precise information about physiol-
ogy along the diseased vessel before exerting any 
insult against the coronary endothelium, other than 
inserting the pressure wire. This information can 
have important logistic advantages, when compared 
with the current practice of guiding intervention by 
DP. In 52.7% of the cases the decision about which 
lesion should be treated first could be left up to the 
operator, who might thus consider other anatomic 
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or interventional parameters in the decision. In 
6 (16.7%) cases the decision was absolutely left to the 
operator’s choice, because both lesions were sig-
nificant, whilst in 13 (36.1%) of cases the decision 
was only partially facultative, because each lesion 
had a predicted FFR > 0.80 separately and only the 
combination of them was significant: in this scenario 
the operator should try to revascularize the lesion 
with the lowest predicted FFR, but he could change 
his target after considering other operational vari-
ables. Therefore, knowing this information upfront 
could be instrumental for the operator in order to 
properly plan the corresponding PCI. The poor 
agreement in different interventional variables 
between the delta approach and the calculation of 
predicted FFR for each lesion indicates indirectly 
the high potential impact of the current formula on 
planning the interventional strategy.
Consequence on alternative methods  
to estimate physiology
Intracoronary physiology is living an unprec-
edented blossom over the last years, with the 
development of a myriad of alternative methods 
to conventional FFR with quite good clinical per-
formance [14–21]. Some of them, like the instant 
wave-free ratio (iFR) or quantitative flow ratio 
(QFR) offer a possibility of estimating the pressure 
drop along the coronary segment. Although these 
methods do not take into account the modification 
of the coronary flow after treatment of one of the 
lesions, their rationale might make sense, because 
they are not calculated under hyperaemic flow 
conditions and the change in flow might be hence 
negligible, unless any of the lesions were so severe 
as to impede even the resting flow. Recent studies 
have successfully validated the usefulness of iFR 
in predicting FFR in sequential stenosis using 
a combination of iFR pullback and virtual PCI tool 
[22]. These approaches show similar accuracy to the 
hereby described method with the advantage of also 
applying the diffuse disease with > 2 focal stenosis. 
Limitations of the study
The current study had a low inclusion rate 
(40 patients in 6 participating centres over 
19 months). This was exclusively due to the unusually 
slow regulatory processes in the corresponding 
countries, to logistic problems and to the incor-
poration at different time points of the participat-
ing centres (4 of them were actively recruiting 
for < 6 months). No patient has been excluded 
after signing the informed consent, irrespective 
of FFR results, to minimize the risk of selection 
bias. Indeed 4 patients coming for scheduled PCI 
based on a previous angiography, who had signed 
the informed consent, did not properly meet the 
inclusion criteria because the distal FFR > 0.80. 
Even these patients are hereby reported, although 
excluded from the main analysis, to approximate 
the estimation of the impact on the PCI strategy to 
a real-world scenario. The sample size of the study 
is modest as it was calculated for a general pilot 
study of validation. Larger studies must be per-
formed to answer to the many questions raised by 
this approach, like an eventual differential accuracy 
in the different coronary vessels or the influence of 
potential sources of inaccuracy that might explain 
the poor agreement in a few outliers.
The use of this formula is limited to the pres-
ence of two clearly discernible stenosis. For > 2 
sequential lesions or for diffuse coronary disease, 
the predicted FFR for each potential target lesion 
cannot be performed as hereby described. Like-
wise, Pijls’ original article excluded patients with 
a large side branch taking off between the lesions 
[7, 8]. This was herein, intentionally skipped as ex-
clusion criterion because the current study aimed 
at assessing the clinical performance of the simpli-
fied formula in a real-world scenario, although this 
decision might have hampered the accuracy of the 
approach in some cases.
The current study used intravenous adenosine 
to create a stable frame of maximal vasodilation that 
enabled reliable measurement of all the required 
parameters. It is uncertain how this formula can 
perform if the vasodilation were differently in-
duced, e.g. by means of intracoronary adenosine 
[23, 24] or by contrast injection [25].
Conclusions
The predicted FFR for each lesion in sequen-
tial coronary stenosis can be accurately calculated 
by a novel simplified formula circumventing the 
need for balloon inflation. This approach can pro-
vide the operator upfront with detailed information 
of the coronary physiology, thus having a poten-
tially high impact on planning the corresponding 
PCI strategy.
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